Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Notification of relapse and other previously treated tuberculosis in the 52 health districts of South Africa.

Marx FM, Cohen T, Lombard C, Hesseling AC, Dlamini SS, Beyers N, Naidoo P.

Int J Tuberc Lung Dis. 2019 Aug 1;23(8):891-899. doi: 10.5588/ijtld.18.0609.

PMID:
31533878
2.

Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).

Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, Yang B, Phiri M, Schaap A, Eshleman SH, Piwowar-Manning E, Kosloff B, James A, Skalland T, Wilson E, Emel L, Macleod D, Dunbar R, Simwinga M, Makola N, Bond V, Hoddinott G, Moore A, Griffith S, Deshmane Sista N, Vermund SH, El-Sadr W, Burns DN, Hargreaves JR, Hauck K, Fraser C, Shanaube K, Bock P, Beyers N, Ayles H, Fidler S; HPTN 071 (PopART) Study Team.

N Engl J Med. 2019 Jul 18;381(3):207-218. doi: 10.1056/NEJMoa1814556.

3.

Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.

Bock P, Nel K, Fatti G, Sloot R, Ford N, Voget J, Gunst C, Grobbelaar N, Louis F, Floyd S, Hayes R, Ayles H, Beyers N, Fidler S; HPTN 071 (PopART) Team.

HIV Med. 2019 Jul;20(6):392-403. doi: 10.1111/hiv.12729. Epub 2019 Apr 8.

4.

Better Virological Outcomes amongst People Living with HIV Initiating Early Antiretroviral Treatment (CD4 counts ≥ 500 cells/µL) in the HPTN 071 (PopART) Trial in South Africa.

Fatti G, Grimwood A, Nachega JB, Nelson JA, LaSorda K, Zyl GV, Grobbelaar N, Ayles H, Hayes R, Beyers N, Fidler S, Bock P; HPTN 071 (PopART) study team.

Clin Infect Dis. 2019 Mar 16. pii: ciz214. doi: 10.1093/cid/ciz214. [Epub ahead of print]

5.

Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia.

Floyd S, Ayles H, Schaap A, Shanaube K, MacLeod D, Phiri M, Griffith S, Bock P, Beyers N, Fidler S, Hayes R; HPTN 071 (PopART) Study Team.

PLoS One. 2018 Aug 10;13(8):e0197904. doi: 10.1371/journal.pone.0197904. eCollection 2018.

6.

Improving rifampicin-resistant tuberculosis diagnosis using Xpert® MTB/RIF: modelling interventions and costs.

Dunbar R, Naidoo P, Beyers N, Langley I.

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):890-898. doi: 10.5588/ijtld.17.0594.

PMID:
29991398
7.

Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.

Bock P, Fatti G, Ford N, Jennings K, Kruger J, Gunst C, Louis F, Grobbelaar N, Shanaube K, Floyd S, Grimwood A, Hayes R, Ayles H, Fidler S, Beyers N; HPTN 071 (PopART) trial team.

PLoS One. 2018 Apr 19;13(4):e0195127. doi: 10.1371/journal.pone.0195127. eCollection 2018.

8.

Factors associated with linkage to HIV care and TB treatment at community-based HIV testing services in Cape Town, South Africa.

Meehan SA, Sloot R, Draper HR, Naidoo P, Burger R, Beyers N.

PLoS One. 2018 Apr 2;13(4):e0195208. doi: 10.1371/journal.pone.0195208. eCollection 2018.

9.

Access to human immunodeficiency virus testing services in Cape Town, South Africa: a user perspective.

Meehan SA, Rossouw L, Sloot R, Burger R, Beyers N.

Public Health Action. 2017 Dec 21;7(4):251-257. doi: 10.5588/pha.17.0052.

10.

What drives 'first-time testers' to test for HIV at community-based HIV testing services?

Meehan SA, Draper HR, Burger R, Beyers N.

Public Health Action. 2017 Dec 21;7(4):304-306. doi: 10.5588/pha.17.0064.

11.

Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study.

Marx FM, Yaesoubi R, Menzies NA, Salomon JA, Bilinski A, Beyers N, Cohen T.

Lancet Glob Health. 2018 Apr;6(4):e426-e435. doi: 10.1016/S2214-109X(18)30022-6. Epub 2018 Feb 19.

12.

Socio-economic gradients in prevalent tuberculosis in Zambia and the Western Cape of South Africa.

Yates TA, Ayles H, Leacy FP, Schaap A, Boccia D, Beyers N, Godfrey-Faussett P, Floyd S.

Trop Med Int Health. 2018 Apr;23(4):375-390. doi: 10.1111/tmi.13038. Epub 2018 Mar 24. Erratum in: Trop Med Int Health. 2018 Aug;23(8):934.

13.

Five-year follow-up of participants diagnosed with chronic airflow obstruction in a South African Burden of Obstructive Lung Disease (BOLD) survey.

Allwood BW, Gillespie R, Bateman M, Olckers H, Taborda-Barata L, Calligaro GL, Van Zyl-Smit R, Cooper CB, Beyers N, Bateman ED.

S Afr Med J. 2018 Feb 1;108(2):138-143. doi: 10.7196/SAMJ.2017.v108i2.12688.

14.

Cost analysis of two community-based HIV testing service modalities led by a Non-Governmental Organization in Cape Town, South Africa.

Meehan SA, Beyers N, Burger R.

BMC Health Serv Res. 2017 Dec 2;17(1):801. doi: 10.1186/s12913-017-2760-8.

15.

Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.

Bock P, Jennings K, Vermaak R, Cox H, Meintjes G, Fatti G, Kruger J, De Azevedo V, Maschilla L, Louis F, Gunst C, Grobbelaar N, Dunbar R, Limbada M, Floyd S, Grimwood A, Ayles H, Hayes R, Fidler S, Beyers N.

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):93-101. doi: 10.1097/QAI.0000000000001560.

16.

Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial.

Thomas R, Burger R, Harper A, Kanema S, Mwenge L, Vanqa N, Bell-Mandla N, Smith PC, Floyd S, Bock P, Ayles H, Beyers N, Donnell D, Fidler S, Hayes R, Hauck K; HPTN 071 (PopART) Study Team.

Lancet Glob Health. 2017 Nov;5(11):e1133-e1141. doi: 10.1016/S2214-109X(17)30367-4. Epub 2017 Sep 27.

17.

Understanding low sensitivity of community-based HIV rapid testing: experiences from the HPTN 071 (PopART) trial in Zambia and South Africa.

Bock P, Phiri C, Piwowar-Manning E, Kosloff B, Mandla N, Young A, James A, Schaap A, Scheepers M, Donnell D, Griffith S, El-Sadr W, Shanaube K, Beyers N, Hayes R, Fidler S, Ayles H; HPTN 071 (PopART) Study Team.

J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):21780. doi: 10.7448/IAS.20.7.21780.

18.

High laboratory cost predicted per tuberculosis case diagnosed with increased case finding without a triage strategy.

Dunbar R, Naidoo P, Beyers N, Langley I.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1026-1034. doi: 10.5588/ijtld.17.0156.

PMID:
28826453
19.

Obstructive pulmonary disease in patients with previous tuberculosis: Pathophysiology of a community-based cohort.

Allwood BW, Gillespie R, Galperin-Aizenberg M, Bateman M, Olckers H, Taborda-Barata L, Calligaro GL, Said-Hartley Q, Van Zyl-Smit R, Cooper CB, Van Rikxoort E, Goldin J, Beyers N, Bateman ED.

S Afr Med J. 2017 Apr 25;107(5):440-445. doi: 10.7196/SAMJ.2017.v107i5.12118.

20.

A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.

Hayes R, Floyd S, Schaap A, Shanaube K, Bock P, Sabapathy K, Griffith S, Donnell D, Piwowar-Manning E, El-Sadr W, Beyers N, Ayles H, Fidler S; HPTN 071 (PopART) Study Team.

PLoS Med. 2017 May 2;14(5):e1002292. doi: 10.1371/journal.pmed.1002292. eCollection 2017 May.

21.

Operational modelling: the mechanisms influencing TB diagnostic yield in an Xpert® MTB/RIF-based algorithm.

Dunbar R, Naidoo P, Beyers N, Langley I.

Int J Tuberc Lung Dis. 2017 Apr 1;21(4):381-388. doi: 10.5588/ijtld.16.0432.

PMID:
28284252
22.

Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys.

Claassens MM, van Schalkwyk C, Floyd S, Ayles H, Beyers N.

PLoS One. 2017 Mar 3;12(3):e0172881. doi: 10.1371/journal.pone.0172881. eCollection 2017.

23.

Has universal screening with Xpert® MTB/RIF increased the proportion of multidrug-resistant tuberculosis cases diagnosed in a routine operational setting?

Naidoo P, Dunbar R, Caldwell J, Lombard C, Beyers N.

PLoS One. 2017 Feb 15;12(2):e0172143. doi: 10.1371/journal.pone.0172143. eCollection 2017.

24.

The association of hyperglycaemia with prevalent tuberculosis: a population-based cross-sectional study.

Bailey SL, Ayles H, Beyers N, Godfrey-Faussett P, Muyoyeta M, du Toit E, Yudkin JS, Floyd S.

BMC Infect Dis. 2016 Dec 5;16(1):733.

25.

HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South Africa.

Hargreaves JR, Stangl A, Bond V, Hoddinott G, Krishnaratne S, Mathema H, Moyo M, Viljoen L, Brady L, Sievwright K, Horn L, Sabapathy K, Ayles H, Beyers N, Bock P, Fidler S, Griffith S, Seeley J, Hayes R; HPTN 071 (PopART) study team.

Health Policy Plan. 2016 Dec;31(10):1342-1354. Epub 2016 Jul 3.

26.

Comparing laboratory costs of smear/culture and Xpert® MTB/RIF-based tuberculosis diagnostic algorithms.

Naidoo P, Dunbar R, du Toit E, van Niekerk M, Squire SB, Beyers N, Madan J.

Int J Tuberc Lung Dis. 2016 Oct;20(10):1377-1385.

PMID:
27725051
27.

Diabetes mellitus in Zambia and the Western Cape province of South Africa: Prevalence, risk factors, diagnosis and management.

Bailey SL, Ayles H, Beyers N, Godfrey-Faussett P, Muyoyeta M, du Toit E, Yudkin JS, Floyd S.

Diabetes Res Clin Pract. 2016 Aug;118:1-11. doi: 10.1016/j.diabres.2016.05.001. Epub 2016 May 7.

28.

High burden of prevalent tuberculosis among previously treated people in Southern Africa suggests potential for targeted control interventions.

Marx FM, Floyd S, Ayles H, Godfrey-Faussett P, Beyers N, Cohen T.

Eur Respir J. 2016 Oct;48(4):1227-1230. doi: 10.1183/13993003.00716-2016. Epub 2016 Jul 7. No abstract available.

29.

Health care workers' gender bias in testing could contribute to missed tuberculosis among women in South Africa.

Smith A, Burger R, Claassens M, Ayles H, Godfrey-Faussett P, Beyers N.

Int J Tuberc Lung Dis. 2016 Mar;20(3):350-6. doi: 10.5588/ijtld.15.0312.

PMID:
27046716
30.

Comparing Tuberculosis Diagnostic Yield in Smear/Culture and Xpert® MTB/RIF-Based Algorithms Using a Non-Randomised Stepped-Wedge Design.

Naidoo P, Dunbar R, Lombard C, du Toit E, Caldwell J, Detjen A, Squire SB, Enarson DA, Beyers N.

PLoS One. 2016 Mar 1;11(3):e0150487. doi: 10.1371/journal.pone.0150487. eCollection 2016.

31.

Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa.

Claassens MM, van Schalkwyk C, Dunbar R, Ayles H, Beyers N.

Emerg Infect Dis. 2016 Mar;22(3):535-7. doi: 10.3201/eid2203.151618.

32.

Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection.

Dodd PJ, Looker C, Plumb ID, Bond V, Schaap A, Shanaube K, Muyoyeta M, Vynnycky E, Godfrey-Faussett P, Corbett EL, Beyers N, Ayles H, White RG.

Am J Epidemiol. 2016 Jan 15;183(2):156-66. doi: 10.1093/aje/kwv160. Epub 2015 Dec 8.

33.

Assessment of previous tuberculosis status using questionnaires, chest X-rays and computed tomography scans.

Allwood BW, Goldin J, Said-Hartley Q, van Zyl-Smit RN, Calligaro G, Esmail A, Beyers N, Bateman ED.

Int J Tuberc Lung Dis. 2015 Dec;19(12):1435-40. doi: 10.5588/ijtld.14.0992.

PMID:
26614183
34.

Optimizing Mycobacterial Culture in Smear-Negative, Human Immunodeficiency Virus-Infected Tuberculosis Cases.

Ismail NA, Said HM, Pinini Z, Omar SV, Beyers N, Naidoo P.

PLoS One. 2015 Nov 6;10(11):e0141851. doi: 10.1371/journal.pone.0141851. eCollection 2015.

35.

Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.

Naidoo P, van Niekerk M, du Toit E, Beyers N, Leon N.

BMC Health Serv Res. 2015 Oct 28;15:488. doi: 10.1186/s12913-015-1145-0.

36.

Factors influencing increased expertise for a sustainable workforce at a research centre in South Africa.

Brand S, Draper HR, Enarson DA, Beyers N, Claassens M.

Public Health Action. 2014 Dec 21;4(4):276-80. doi: 10.5588/pha.14.0057.

37.

Symptom reporting among prevalent tuberculosis cases who smoke, are HIV-positive or have hyperglycaemia.

Sattar S, Van Schalkwyk C, Claassens M, Dunbar R, Floyd S, Enarson DA, Godfrey-Faussett P, Ayles H, Beyers N.

Public Health Action. 2014 Dec 21;4(4):222-5. doi: 10.5588/pha.14.0081.

39.

Comparing multidrug-resistant tuberculosis patient costs under molecular diagnostic algorithms in South Africa.

du Toit E, Squire SB, Dunbar R, Machekano R, Madan J, Beyers N, Naidoo P.

Int J Tuberc Lung Dis. 2015 Aug;19(8):960-8. doi: 10.5588/ijtld.14.0703.

PMID:
26162363
40.

The complex relationship between human immunodeficiency virus infection and death in adults being treated for tuberculosis in Cape Town, South Africa.

Osman M, Seddon JA, Dunbar R, Draper HR, Lombard C, Beyers N.

BMC Public Health. 2015 Jun 18;15:556. doi: 10.1186/s12889-015-1914-z.

41.

HIV treatment-as-prevention research: taking the right road at the crossroads.

Hayes R, Fidler S, Cori A, Fraser C, Floyd S, Ayles H, Beyers N, El-Sadr W; HPTN 071 (PopART) Study Team.

PLoS Med. 2015 Mar 10;12(3):e1001800. doi: 10.1371/journal.pmed.1001800. eCollection 2015 Mar.

42.

Characteristics of clients who access mobile compared to clinic HIV counselling and testing services: a matched study from Cape Town, South Africa.

Meehan SA, Naidoo P, Claassens MM, Lombard C, Beyers N.

BMC Health Serv Res. 2014 Dec 20;14:658. doi: 10.1186/s12913-014-0658-2.

43.

Balancing the need to rapidly scale-up and improve clinical outcomes in antiretroviral programmes in developing countries: lessons from an Indian programmatic cohort study.

Bock P, Beyers N, Fidler S.

Trans R Soc Trop Med Hyg. 2014 Oct;108(10):599-600. doi: 10.1093/trstmh/tru126. Epub 2014 Aug 6.

PMID:
25100793
44.

A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town.

Naidoo P, du Toit E, Dunbar R, Lombard C, Caldwell J, Detjen A, Squire SB, Enarson DA, Beyers N.

PLoS One. 2014 Jul 31;9(7):e103328. doi: 10.1371/journal.pone.0103328. eCollection 2014.

45.

Applying ethical principles to international community-based research: a case study from the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE) .

Kass NE, DeLuca AN, Coetzee L, Simwinga M, Churchyard GJ, Ayles H, Beyers N, Godfrey-Faussett P, Durovni B, Chaisson RE, Eldred LJ.

IRB. 2014 May-Jun;36(3):1-8. No abstract available.

PMID:
24946506
46.

How do we measure the success of operational research?

Naidoo P, Wills C, Enarson DA, Beyers N.

Public Health Action. 2014 Jun 21;4(2):74. doi: 10.5588/pha.14.0056. No abstract available.

47.

Integration of TB and ART services fails to improve TB treatment outcomes: comparison of ART/TB primary healthcare services in Cape Town, South Africa.

Kaplan R, Caldwell J, Bekker LG, Jennings K, Lombard C, Enarson DA, Wood R, Beyers N.

S Afr Med J. 2014 Mar;104(3):204-9.

PMID:
24897825
48.

Missed opportunities for retention in pre-ART care in Cape Town, South Africa.

du Toit E, van Schalkwyk C, Dunbar R, Jennings K, Yang B, Coetzee D, Beyers N.

PLoS One. 2014 May 7;9(5):e96867. doi: 10.1371/journal.pone.0096867. eCollection 2014.

49.

The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study.

Marx FM, Dunbar R, Enarson DA, Williams BG, Warren RM, van der Spuy GD, van Helden PD, Beyers N.

Clin Infect Dis. 2014 Jun;58(12):1676-83. doi: 10.1093/cid/ciu186. Epub 2014 Mar 18.

PMID:
24647020
50.

Sex-related trends in non-conversion of new smear-positive tuberculosis patients in the Free State, South Africa.

Heunis JC, Kigozi NG, van der Merwe S, Chikobvu P, Beyers N.

Public Health Action. 2014 Mar 21;4(1):66-71. doi: 10.5588/pha.13.0108.

Supplemental Content

Loading ...
Support Center